RAPT Therapeutics, Inc. (RAPT)
Mar 3, 2026 - RAPT was delisted (reason: acquired by GSK)
58.02
0.00 (0.00%)
Inactive · Last trade price
on Mar 2, 2026
RAPT Therapeutics Employees
RAPT Therapeutics had 68 employees as of December 31, 2024. The number of employees decreased by 63 or -48.09% compared to the previous year.
Employees
68
Change (1Y)
-63
Growth (1Y)
-48.09%
Revenue / Employee
n/a
Profits / Employee
-$1,760,617
Market Cap
1.79B
Employees Chart
RAPT News
- 5 weeks ago - Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 6 weeks ago - Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK - GlobeNewsWire
- 6 weeks ago - RAPT Therapeutics shares surge 64% as GSK agrees $2.2B acquisition - Invezz
- 6 weeks ago - GSK to buy food allergy drug maker RAPT in $2.2bn deal - The Guardian
- 6 weeks ago - This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. - Barrons
- 6 weeks ago - GSK to buy RAPT Therapeutics for $2.2 billion - Reuters
- 7 weeks ago - RAPT Therapeutics, Inc. (RAPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire